Collaboration Resources
Dr. Guang-Shing Cheng, and recent medical school graduate Dr. Madelyn Peha presenting their research at American Thoracic Society 2022 International Conference in San Francisco.
ATS 2023, Washington, D.C. Consortium Dinner with collaborators. From Left: Drs. Guang-Shing Cheng (Fred Hutch), Jeffrey Sturek (University of Virginia), Scott Evans (MDACC), Charles Dela Cruz (Yale), Ajay Sheshadri (MDACC), and Anne Bergeron (Universitaires de Genève).
Patient Resources
Blood & Marrow Transplant Information Network
The Blood & Marrow Transplant Information Network (BMT InfoNet) is a leading advocacy organization for transplant and CAR T-cell therapy recipients before, during and after treatment.
Learn More
Monthly Meetings
Monthly meetings include main contributors from core sites and collaborating consortium sites with the overall goal to learn, share science, facilitate collaborations, as well as form content. Occassionally we discuss research that is not published and as such, recordings of those meetings will not be posted.
View Lung GVHD Meeting Inventory
Meeting minutes and recordings by date:
- October 24, 2024
- November 21, 2024
- December 19, 2024
Active Consortium Projects
10095 Early Detection of Bronchiolitis Obliterans Syndrome with Home Spirometry in Survivors of Allogeneic Hematopoietic Cell Transplant
- PI: Guang-Shing Cheng (Fred Hutch)
- Sponsor: the 2019 V Foundation Robin Roberts Thrivership Fund
- Status: closed to accrual
- RG #: RG1005061
- NCI Trial ID: NCI-2021-08187
R01: Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant (RV-BOS Study)
- PI: Guang-Shing Cheng (Fred Hutch)
- Sponsor: NIH/NHLBI
- Status: open to accrual
- RG #: RG1121806
- NCI Trial ID: NCI-2021-13375
- View Clinicaltrials.gov trial information
R01: Parametric Response Mapping for Chronic Lung Disease after Hematopoietic Cell Transplant (PRM for CLD)
- PIs: Dr. Greg Yanik and Dr. Craig Galban (University of Michigan)
- Sponsor: NIH/NHLBI
- Status: open to accrual
- RG #: RG1123197
- NCI Trial ID: NCT05866302
- View Clinicaltrials.gov trial information
Prospective Study to Investigate Acute Respiratory Virus Infections in Patients at High Risk for Severe Illness: BREEZE
- Site PI: Guang-Shing Cheng, MD (Fred Hutch)
- Sponsor: Janssen RVI
- RG #: RG1123397
© 2025 Fred Hutchinson Cancer Center, a 501(c)(3) nonprofit organization.